Additionally, they discovered that BC-CML-initiating cells had higher levels of BCAT1 mRNA, and that transduction of shRNA targeting BCAT1 mRNA reduced intracellular BCAA levels, which impeded the ability to form colonies in vitro. This evidence concerns the gene BCAT1 and breast cancer.